Literature DB >> 22354163

Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics.

Andjela Baewert1, Reinhold Jagsch, Bernadette Winklbaur, Gerda Kaiser, Kenneth Thau, Annemarie Unger, Constantin Aschauer, Manfred Weninger, Verena Metz.   

Abstract

BACKGROUND: Multi-center trials enable the recruitment of larger study samples, although results might be influenced by site-specific factors.
METHODS: Site differences of a multi-center prospective double-blind, double-dummy randomized controlled trial (7 centers: Central Europe (Vienna)/USA (3 urban/3 rural centers)) comparing safety and efficacy of methadone and buprenorphine in pregnant opioid-dependent women and their neonates.
RESULTS: Urban US women had the highest rate of concomitant opioid (p = 0.050) and cocaine consumption (p = 0.003), the highest dropout rate (p = 0.001), and received the lowest voucher sums (p = 0.001). Viennese neonates had significantly higher Apgar scores 1 min (p = 0.001) and 5 min after birth (p < 0.001) and were more often born by cesarean section (p = 0.024). Rural US newborns had a significantly shorter neonatal abstinence syndrome treatment duration compared to Viennese and urban US sites (p = 0.006), in addition to other site-specific differences, suggesting a more severely affected group of women in the urban US sites.
CONCLUSION: This clinical trial represents a role model for pharmacological treatment in this unique sample of pregnant women and demonstrates the clinical importance of considering site-specific factors in research and clinical practice.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354163      PMCID: PMC3696360          DOI: 10.1159/000335082

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  42 in total

1.  Treatment of opioid dependence in pregnant women.

Authors:  G Fischer
Journal:  Addiction       Date:  2000-08       Impact factor: 6.526

2.  Neonatal abstinence syndrome: assessment and management.

Authors:  L P Finnegan; J F Connaughton; R E Kron; J P Emich
Journal:  Addict Dis       Date:  1975

Review 3.  Neuroimaging of children following prenatal drug exposure.

Authors:  Chris Derauf; Minal Kekatpure; Nurunisa Neyzi; Barry Lester; Barry Kosofsky
Journal:  Semin Cell Dev Biol       Date:  2009-03-13       Impact factor: 7.727

4.  Sleep problems in children with prenatal substance exposure: the Maternal Lifestyle study.

Authors:  Kristen C Stone; Linda L LaGasse; Barry M Lester; Seetha Shankaran; Henrietta S Bada; Charles R Bauer; Jane A Hammond
Journal:  Arch Pediatr Adolesc Med       Date:  2010-05

5.  The role of patient satisfaction in methadone treatment.

Authors:  Sharon M Kelly; Kevin E O'Grady; Barry S Brown; Shannon Gwin Mitchell; Robert P Schwartz
Journal:  Am J Drug Alcohol Abuse       Date:  2010-05       Impact factor: 3.829

6.  Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.

Authors:  Hendree E Jones; Rolley E Johnson; Donald R Jasinski; Kevin E O'Grady; Christian A Chisholm; Robin E Choo; Michael Crocetti; Robert Dudas; Cheryl Harrow; Marilyn A Huestis; Lauren M Jansson; Michael Lantz; Barry M Lester; Lorraine Milio
Journal:  Drug Alcohol Depend       Date:  2005-07       Impact factor: 4.492

7.  Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment.

Authors:  A S Unger; P R Martin; K Kaltenbach; S M Stine; S H Heil; H E Jones; A M Arria; M G Coyle; P Selby; G Fischer
Journal:  Eur Addict Res       Date:  2010-02-17       Impact factor: 3.015

8.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

9.  Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.

Authors:  Tomás Binder; Blanka Vavrinková
Journal:  Neuro Endocrinol Lett       Date:  2008-02       Impact factor: 0.765

Review 10.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14
View more
  3 in total

1.  Incidence of narcotic abuse during pregnancy in northwestern Ontario: three-year prospective cohort study.

Authors:  Len Kelly; John Guilfoyle; Joe Dooley; Irwin Antone; Lianne Gerber-Finn; Roisin Dooley; Nicole Brunton; Kara Kakegamuck; Jill Muileboom; Wilma Hopman; Helen Cromarty; Barb Linkewich; Jennifer Maki
Journal:  Can Fam Physician       Date:  2014-10       Impact factor: 3.275

2.  Narcotic tapering in pregnancy using long-acting morphine: an 18-month prospective cohort study in northwestern Ontario.

Authors:  Roisin Dooley; Joe Dooley; Irwin Antone; John Guilfoyle; Lianne Gerber-Finn; Kara Kakekagumick; Helen Cromarty; Wilma Hopman; Jill Muileboom; Nicole Brunton; Len Kelly
Journal:  Can Fam Physician       Date:  2015-02       Impact factor: 3.275

Review 3.  Rural, Pregnant, and Opioid Dependent: A Systematic Review.

Authors:  Naana Afua Jumah
Journal:  Subst Abuse       Date:  2016-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.